All News

A cancer survivor searches for the right way to bid farewell to a dying friend.

This is the first approval in the small cell lung cancer space in nearly two decades.

The Food and Drug Administration (FDA) approved Lenvima (lenvatinib) for the firstline treatment of patients with unresectable hepatocellular carcinoma (HCC).

Researchers noted that melanoma diagnosis and treatment did not cause many women to put off becoming pregnant.

It takes a village to support someone through a cancer diagnosis.

I call it cancer motivation. Whenever I get annoyed about doing something that's not my favorite, like a long 10K race, I think about surviving cancer and those that did not. It becomes my motivation to take a breath and enjoy each second.

Individuals diagnosed with a high frequency of basal cell carcinomas, a common type of skin cancer, may be at an increased for developing an unrelated cancer, highlighting the need for additional clinical screening.

In recent years, immunotherapy has been falling flat in the brain cancer field, but recent research may change that.

When life deals you the cancer card, make your own deck with special role models to help you remember how strong a person with cancer can be. Sometimes little reminders to ourselves in our best handwriting can help us through a rough patch.

If you're using your 'cancer following' to gain fame or profit for yourself, I ask you to reconsider.

A patient's bone health history may offer clues into their myeloma outcomes, according to a recent study.

Learning to live life with lymphedema is challenging. The life changes it presents can cause many negative emotions. but you don't have to loathe life just because you have a chronic medical condition.

Life as a cancer survivor can feel like a balancing act. One day you may be dancing with joy, and the next you might be struggling with fear. Support and understanding can come as we help people around us understand the struggle.

Recent research showed first-degree relatives of patients with certain types of blood cancers may be at an increased risk for such disease, highlighting the importance of counseling, gene testing and surveillance.

The FDA has granted a priority review designation to a biologics license application (BLA) for SL-401 (tagraxofusp, Elzonris) for the treatment of patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN), according to Stemline Therapeutics, the developer of the novel stemness inhibitor.

The combination use of Tumor Treating Fields plus paclitaxel more than doubled progression-free survival, with no serious treatment-related side effects in women with recurrent, platinum-resistant ovarian cancer.

Dewayne Johnson, a patient with cancer who claimed that Monsanto’s Roundup product was at the root of his non-Hodgkin lymphoma diagnosis in 2014, was awarded $289 million by a jury, as reported by the Associated Press.

The Summer 2018 issue is out! And we have a sneak peek at what’s inside.

A cancer survivors take on comments regarding cancer.

Don't get stuck hanging out at the stop sign, advises a two-time cancer survivor.

It is not always easy to know what to say to a loved one who was just diagnosed with cancer. Here are some dos and don'ts that may help. But remember, every person is different.

The potential differences in the genetic risk factors among men and women for developing glioma may shed light on a new way to assess such risks, according to a meta-analysis published in Scientific Reports.

It's easy to identify with others who share our kind of cancer, but what about the rest?

It is possible after December 31, 2018, we may see a new way to reward wellness. Could this impact future cancer rates if we embrace a wellness mindset while also saving money?

After Barbara Demorest underwent a mastectomy, a silicone-based prosthetic seemed to be her only option, until her doctor asked a question that would change her life: “Do you knit?”

Lost homes, delayed treatments, death. Metastatic breast cancer patients have a shot at changing the access paradigm.

Understanding these outcomes is important in planning treatments and mitigating the possibility of patients stopping their treatment.

In a global analysis, researchers found global lung cancer mortality rates are projected to increase by 43 percent in women; however, breast cancer rates should decline by 9 percent.